Development of severe sclerotic chronic GVHD during treatment with dasatinib

Bone Marrow Transplant. 2010 Sep;45(9):1469-70. doi: 10.1038/bmt.2009.368. Epub 2010 Jan 11.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Chronic Disease
  • Combined Modality Therapy
  • Dasatinib
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / pathology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / adverse effects*
  • Sclerosis
  • Severity of Illness Index
  • Thiazoles / adverse effects*
  • Young Adult

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib